Coronavirus Update: Warp Speed Companies Grilled On Vaccine Safety, Price And Timelines
Two Companies Commit To Not-For-Profit Supply
House committee seeks reassurances on a range of issues, including the security of a US vaccines supply chain against a background of rising tensions with China.
You may also be interested in...
The US government’s order of 100 million doses for $1.95bn means the implied price for Pfizer/BioNtech's vaccine is $19.50 per dose. That could set a benchmark for solid near-term revenue and profitability for companies in the space.
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Viatris debuts; Chi-Med charts its own path; Novo takes another go at obesity; Sangamo moves forward with CAR-Treg; Intercept readies for resubmission; and ImmunoGen is relying on a safety advantage for its ADC.